Enzymatic DNA synthesis sales will expand through 2036, with oligonucleotide synthesis holding 59.3% of the services outlook segment in 2026. The market was valued at USD 0.37 billion in 2025 and is expected to be worth USD 5.01 billion by 2036, creating an incremental opportunity of USD 4.54 billion.